PDCD1 and neoplasm: This being the case, a TMZ treatment effect would recruit tumour infiltrating lymphocytes whose action would be enhanced by the next turn of immune checkpoint inhibitor anti-PD-1 administration (see proposed schema in Figure 7), taking place 6 days after the initial TMZ administration.